3-(butylamino)-4-(4-hydroxyphenoxy)-5-sulfamoylbenzoic acid is a chemical compound identified as an impurity associated with the pharmaceutical manufacturing of regorafenib. It serves as a reference standard or intermediate in quality control and research settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 94610-14-7
Bumetanide
pharmaceutical raw material
Methyl 2-fluoro-3-nitrobenzoate
pharmaceutical intermediate
Albendazole EP Impurity J
pharmaceutical intermediate
2-Trifluoromethoxybenzaldehyde
pharmaceutical intermediate
2-ethylbutyl (2S)-2-aminopropanoate;hydrochloride
pharmaceutical intermediate
3-(butylamino)-4-(4-hydroxyphenoxy)-5-sulfamoylbenzoic acid
SQMCKUGGMUJIRF-UHFFFAOYSA-N
CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=C(C=C2)O
—